In a report released yesterday, Eric Serotta from Morgan Stanley initiated coverage with a Buy rating on Philip Morris (PM – Research Report) and a price target of $140.00. The company’s ...

Barclays analyst Gaurav Jain maintained a Buy rating on Philip Morris (PM – Research Report) today and set a price target of $145.00. The company’s shares closed yesterday at $130.32.

Be the first to get news, photos, videos & more.

The market expects Philip Morris (PM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at www.pmi.com/2024Q4earnings on Thursday, February 6, 2025, at 9:00 a.m. ET, to ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris International, which faced a yearslong decline in cigarette smoking.

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

"At the end of the week, you will be an entirely different person," the trailer for Season 3 of "The White Lotus" begins. The trailer, which debuted on Jan. 27, shows groups of guests drinking ...

Philip Haywood, Kentucky’s all-time winningest ... to him and how they had become friends despite their contrasting backgrounds. “A lot of people stereotype that city guys can’t get along ...

Broberg is being evaluated by the Blues' medical team after leaving Wednesday's practice session early, Lou Korac of NHL.com reports. Broberg is currently stuck in a 10-game goal drought during ...

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against other best sin stocks to invest in 2025. Sin stocks are shares of companies involved ...

The life that Watson had with Sherlock is not done with him,” executive producer Craig Sweeny promises of the new CBS drama starring Morris Chestnut as the iconic doctor, John Watson.